ATE478668T1 - Pyrroloä1,2-aüimidazoldion zur behandlung von peripherer neurotoxizität durch chemotherapeutische mittel - Google Patents

Pyrroloä1,2-aüimidazoldion zur behandlung von peripherer neurotoxizität durch chemotherapeutische mittel

Info

Publication number
ATE478668T1
ATE478668T1 AT07847162T AT07847162T ATE478668T1 AT E478668 T1 ATE478668 T1 AT E478668T1 AT 07847162 T AT07847162 T AT 07847162T AT 07847162 T AT07847162 T AT 07847162T AT E478668 T1 ATE478668 T1 AT E478668T1
Authority
AT
Austria
Prior art keywords
pyrroloä1
aüimidazoldione
treatment
chemotherapeutic agents
peripheral neurotoxicity
Prior art date
Application number
AT07847162T
Other languages
English (en)
Inventor
Carlo Farina
Carla Ghelardini
Paola Petrillo
Original Assignee
Neurotune Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37882430&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE478668(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Neurotune Ag filed Critical Neurotune Ag
Application granted granted Critical
Publication of ATE478668T1 publication Critical patent/ATE478668T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07847162T 2006-11-15 2007-11-14 Pyrroloä1,2-aüimidazoldion zur behandlung von peripherer neurotoxizität durch chemotherapeutische mittel ATE478668T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06124142A EP1925304A1 (de) 2006-11-15 2006-11-15 Pyrrolo[1,2-a]imidazoledione zur Behandlung von durch Chemotherapie ausgelöster peripherer Neuropathie
PCT/EP2007/062323 WO2008058988A1 (en) 2006-11-15 2007-11-14 Pyrrolo[1,2-a]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents

Publications (1)

Publication Number Publication Date
ATE478668T1 true ATE478668T1 (de) 2010-09-15

Family

ID=37882430

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07847162T ATE478668T1 (de) 2006-11-15 2007-11-14 Pyrroloä1,2-aüimidazoldion zur behandlung von peripherer neurotoxizität durch chemotherapeutische mittel

Country Status (19)

Country Link
US (1) US7973066B2 (de)
EP (2) EP1925304A1 (de)
JP (1) JP2010509389A (de)
CN (1) CN101605541A (de)
AR (1) AR063819A1 (de)
AT (1) ATE478668T1 (de)
AU (1) AU2007321218A1 (de)
BR (1) BRPI0718904A2 (de)
CA (1) CA2669853A1 (de)
CL (1) CL2007003281A1 (de)
DE (1) DE602007008759D1 (de)
EA (1) EA200900552A1 (de)
ES (1) ES2347380T3 (de)
IL (1) IL198689A0 (de)
MX (1) MX2009005125A (de)
NZ (1) NZ576995A (de)
PE (1) PE20081494A1 (de)
WO (1) WO2008058988A1 (de)
ZA (1) ZA200904148B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20030573A1 (it) * 2003-03-24 2004-09-25 Nikem Research Srl Composti ad azione nootropica, loro preparazione,
US9125898B2 (en) 2008-11-14 2015-09-08 Neurotune Ag Acetam derivatives for pain relief
RU2017106172A (ru) * 2014-07-31 2018-08-28 Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед Применение антагонистов cxcr2 для предотвращения и/или лечения периферической невропатии, вызванной химиотерапией (cipn)
PL4025183T3 (pl) * 2019-09-02 2025-09-22 Syddansk Universitet Induktory P-gp do stosowania w ochronie przed skutkami ubocznymi chemioterapii takimi jak neuropatia obwodowa wywołana chemioterapią (CIPN) oraz utrata włosów

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20030573A1 (it) * 2003-03-24 2004-09-25 Nikem Research Srl Composti ad azione nootropica, loro preparazione,

Also Published As

Publication number Publication date
EP1925304A1 (de) 2008-05-28
NZ576995A (en) 2010-12-24
JP2010509389A (ja) 2010-03-25
ES2347380T3 (es) 2010-10-28
BRPI0718904A2 (pt) 2013-12-10
US7973066B2 (en) 2011-07-05
IL198689A0 (en) 2010-02-17
AR063819A1 (es) 2009-02-18
AU2007321218A1 (en) 2008-05-22
EP2094265A1 (de) 2009-09-02
US20100062077A1 (en) 2010-03-11
MX2009005125A (es) 2009-11-02
CN101605541A (zh) 2009-12-16
ZA200904148B (en) 2010-04-28
WO2008058988A1 (en) 2008-05-22
DE602007008759D1 (de) 2010-10-07
PE20081494A1 (es) 2008-12-19
EP2094265B1 (de) 2010-08-25
CA2669853A1 (en) 2008-05-22
EA200900552A1 (ru) 2009-10-30
CL2007003281A1 (es) 2008-06-27

Similar Documents

Publication Publication Date Title
EP2046315A4 (de) Therapeutische mittel zur behandlung maligner lymphome
ATE434620T1 (de) Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
EP2021352A4 (de) Behandlung von protein-missfaltung
DE602005015234D1 (de) Zusammensetzungen zur wäschebehandlung
DE602005014252D1 (de) Zusammensetzungen zur wäschebehandlung
EP2034844A4 (de) Verfahren für die behandlung von reizdarm-syndrom des diarrhö-typs
ATE550329T1 (de) Heterobicyclische sulfonamidderivate zur behandlung von diabetes
EP1981526A4 (de) Adiponectin zur behandlung verschiedener erkrankungen
EP2175873A4 (de) Behandlung von angstzuständen
DE602006020327D1 (de) 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-aminder-hemmer zur behandlung thromboembolischer erkrankungen
ATE554091T1 (de) Aminotetrahydropyrane als dipeptidylpeptidase-iv- inhibitoren zur behandlung oder prävention von diabetes
DE602005026984D1 (de) Chinolin-derivate zur behandlung von latenter tuberkulose
ATE527241T1 (de) Pyridiazinonderivate zur behandlung von tumoren
ATE429218T1 (de) Pinolensäure zur behandlung von übergewicht
ATE532507T1 (de) Neramexane zur behandlung von subakuten tinnitus
ATE521365T1 (de) Kinin-antagonisten zur behandlung von blasenfunktionsstörung
LTC2805723I2 (lt) Kladribino režimas, skirtas išsėtinei sklerozei gydyti
EP2249765A4 (de) Dapson zur behandlung von rosascea
EP1965827A4 (de) Behandlung von entmyelinisierenden erkrankungen
EP1905452A4 (de) Wirkstoff zur prävention oder behandlung von glaukomen
DE602006010449D1 (de) Behandlung von geflügel zwecks reduzierung der futon ascites
ATE532787T1 (de) Polycyclische mittel zur behandlung von infektionen mit dem respiratory syncytial virus
DE602006021192D1 (de) Visnadin zur Behandlung von Kopfhautjucken
ATE478668T1 (de) Pyrroloä1,2-aüimidazoldion zur behandlung von peripherer neurotoxizität durch chemotherapeutische mittel
DE502006008804D1 (de) Neue, langwirksame betamimetika zur behandlung von atemwegserkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties